Scientific Name: Docosanol
Brand Name: Abreva
Company Owner: Glaxosmithkline
Mechanism Of Action Docosanol works by inhibiting fusion between the human cell plasma membrane and the herpes simplex virus (HSV) envelope, thereby preventing viral entry into cells and subsequent viral replication. Unlike other cold-sore antivirals, docosanol does not act directly on the virus, and as such it is unlikely it will produce drug resistant mutants of HSV.
Description of the Drug: Docosanol is an antiviral used to treat orofacial herpes sores.
Protein Data Bank: Not Available
Source: DrugBank Online – Retrieved 2023-01-23 from